8/13/2019NHC Releases List of Trial Site Cities of Urban Medical Consortium Exp...

8/13/2019Natco Pharma Seeks to Scale Up China Business

8/13/2019State Council Introduces New Policy with Healthcare Reform Provisions

8/12/2019Chinese Precision Medicine Market Set to Witness a Robust CAGR of 12.8...

8/12/2019CASI Pharmaceuticals Announces Launch of EVOMELA (melphalan for inject...

8/12/2019Nanjing King-Friend to Invest US$95M in Injectable Specialist Meitheal...

8/12/2019SMEI: Review of Chinese Terminal Drug Markets in 2010-H1/2019

8/12/2019SMEI: Review of Chinese Retail Pharmacy Sales 2013-2018

8/12/2019Digital Must Deliver Both Speed and Depth

8/12/2019Eli Lilly Wins New Indication of Cialis in China

8/11/2019Sale of U.S. Taxpayer-Funded New Antibiotic to Qilu Pharma Questioned

8/11/2019Gilead's HIV Drug Biktarvy Approved in China

8/11/2019China Restricts Opioid in Move to Tighten Painkiller Controls

8/11/2019Recent Executive Moves

8/8/2019Chinese Government Forms National Level Advisory Committee for Researc...

8/8/2019Hospital Market and MNCs Rose Higher in Q1/2019 amid Growing Uncertain...

8/7/2019Ascletis Received IND Approval and Management Outlook of 2019 and Beyo...

8/7/2019Mitsubishi Tanabe ALS Drug Edaravone Approved in China

8/7/2019CStone to Build Global R&D HQ and Manufacturing Center in the Suzh...

8/6/2019Innovent and Shenogen to Jointly Evaluate Tyvyt (Sintilimab) in Combin...

8/6/2019Pentagon Sees Security Threat in Chinese Drug-Supply Dominance

8/6/2019NHSA Begins Preparation for Expanded 4+7 Trial

8/6/2019China Issues New Action Plan Against Irregularities in Healthcare

8/6/2019CDE Publicizes 15 Drug Applications To Be Granted Priority Review Stat...

8/5/20193SBio's Enbrel Biosimilar To Be Available as Pre-filled Syringe in Chi...

8/5/2019Central Government to Reform Electronic Bills/Invoices/Receipts for Me...

8/5/2019CPhC Publicizes Technical Guidelines for Premix and Co-treatment of Ph...

8/2/2019I-Mab and TRACON Initiate Phase 1 Trial of CD73 Antibody TJD5

8/2/2019Chinese Drug Developer I-Mab Biopharma Files for U.S. IPO

8/2/2019Dealing with the Chinese Challenge: The Case of the Pharma Industry

Page:216/720 Total number of articles:21572: [First][<<] [214] [215] [216] [217] [218] [>>] [End]